UFP Technologies Inc key statistics and ratios
In fiscal 2025, UFP Technologies Inc had return on equity of 17.8% and a net margin of 11.3%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | 6.0% | 7.7% | 8.1% | 8.3% | 8.1% | 5.4% | 5.5% | 5.5% | 6.2% | 7.5% | 10.0% | 7.5% | 7.7% | 11.8% | 11.2% | 11.7% | 11.3% | 11.4% |
| Return on equity | 15.2% | 20.8% | 18.6% | 16.2% | 14.2% | 8.4% | 7.6% | 7.4% | 7.8% | 10.8% | 13.1% | 7.9% | 8.6% | 19.3% | 17.2% | 18.8% | 17.8% | 16.3% |
| Return on assets | — | 13.3% | 13.9% | 12.2% | 11.1% | 7.0% | 6.5% | 6.4% | 6.9% | 8.7% | 10.4% | 6.8% | 5.9% | 11.7% | 11.5% | 11.4% | 10.6% | 10.8% |
| Effective tax rate | 32.0% | 34.8% | 31.3% | 34.3% | 34.4% | 35.8% | 35.3% | 35.3% | 22.3% | 22.2% | 16.5% | 17.9% | 25.1% | 20.7% | 16.7% | 19.2% | 17.2% | 18.4% |
| R&D as % of revenue | — | 0.7% | 0.9% | 1.0% | 0.9% | 1.0% | 0.9% | 0.9% | 3.4% | 5.5% | 4.4% | 4.6% | 4.1% | 2.6% | 1.8% | 2.1% | 1.4% | — |
| SG&A as % of revenue | 18.7% | 16.8% | 16.8% | 16.5% | 17.0% | 17.1% | 17.3% | 16.5% | 16.0% | 14.5% | 14.7% | 15.3% | 14.3% | 12.9% | 12.7% | 12.3% | 12.8% | 13.3% |
Financial health
- Short-term assets cover short-term liabilities $235m of assets due within a year against $78m of liabilities due within a year.
- Short-term assets cover long-term liabilities $235m short-term assets against $141m of longer-dated liabilities.
- More cash than debt $9m of cash against $117m of debt.
- Debt below 40% of shareholders' equity Debt is 25% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 37% to 25% over five years.
- A year's operating cash flow covers at least 20% of debt $72m of operating cash flow against $117m of debt.
- Operating profit covers interest at least five times over Operating income of $96m against $8m of interest.
Moat
Moderate moat
How hard UFP Technologies's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 14 / 20
Cash operating profit has been a median 11.0% of total assets over 7 years.
- Pricing power 10 / 20
Gross margin has been a median 26.3%, moving by 1.7 percentage points (standard deviation) across 10 years.
- Durability 12 / 20
Operating margin has been a median 11.4%; its worst year was 7.8%.
- Cash conversion 14 / 20
Free cash flow was positive in 9 of 10 years, at a median 9.5% of revenue.
- Discipline 16 / 20
The diluted share count rose 3.0% over five years; stock-based pay has been a median 1.0% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (65 before it).
Compare with peers
- Organogenesis Holdings Inc. statistics
- Embecta Corp. statistics
- Mimedx Group, Inc. statistics
- ICU Medical Inc statistics
- Envista Holdings Corp statistics
Head to head: ORGO vs UFPTEMBC vs UFPTMDXG vs UFPT
More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies